Business, energy, technology, markets and global industry news from Business News Today

infectious disease diagnostics

PharmaDeviceNews infectious disease diagnostics
Representative image of protected laboratory workers conducting rapid molecular testing, illustrating Cepheid’s Xpert Hemorrhagic Fever panel deployment to address Ebola Bundibugyo diagnostic gaps in Africa.
Medical Devices & Diagnostics

Cepheid’s Xpert panel could reshape Ebola outbreak diagnostics, but scale is the real test

Find out how Cepheid’s Xpert Hemorrhagic Fever panel could reshape Ebola Bundibugyo testing in Africa amid urgent diagnostic gaps.

Read More
Representative image of a clinical diagnostics laboratory, illustrating how Zepto Life Technology’s FungiFlex Mold Panel could bring liquid biopsy testing into faster diagnosis of invasive mold infections.
Medical Devices & Diagnostics

Why Zepto Life Technology’s FDA breakthrough status matters for infectious disease diagnostics

Zepto’s FungiFlex brings liquid biopsy to invasive mold infections. The FDA designation tests whether faster fungal diagnosis can change care.

Read More
Representative image: A generic diagnostic test setup illustrates how blood-based lateral flow testing could support Ebola triage and treatment monitoring as VolitionRx advances patent protection for its Nu.Q NETs platform.
Medical Devices & Diagnostics

Why VolitionRx is positioning Nu.Q NETs beyond sepsis and into Ebola monitoring

Find out how VolitionRx’s Nu.Q NETs patent filing could reshape Ebola triage, outbreak diagnostics, and treatment monitoring.

Read More
Medical Devices & Diagnostics

Why Seek Labs’ amplification chemistry could matter beyond infectious disease testing

Molecular testing is powerful but lab-bound. Seek Labs’ patent raises a sharper question: can point-of-care diagnostics finally scale?

Read More
Medical Devices & Diagnostics

Can Karius and Mayo Clinic Laboratories push metagenomic infectious disease testing closer to routine hospital use?

Karius and Mayo Clinic Laboratories are expanding access to rapid metagenomic infection tests. Read what this could change for hospital diagnostics.

Read More
Bruker expands MALDI Biotyper workflows as microbiology labs push for faster outbreak detection
Medical Devices & Diagnostics

Why Bruker’s ESCMID 2026 microbiology expansion could matter for hospital labs and infection control

Bruker expanded its microbiology portfolio at ESCMID 2026. Read what the new MALDI and outbreak tools could mean for labs and infection control.

Read More
Representative image of a rapid diagnostic system used in hospital laboratories, reflecting how Pattern Bioscience’s pneumonia ID AST panel aims to deliver faster phenotypic results for critically ill patients and improve antibiotic decision making in ICU settings.
Medical Devices & Diagnostics

Is culture-free pneumonia testing finally viable as Pattern Bioscience nears regulatory submission

Pattern Bioscience advances rapid pneumonia diagnostics toward FDA clearance. Discover what this means for ICU care and antibiotic resistance.

Read More
QIAGEN wins FDA clearance for gastrointestinal panels on QIAstat-Dx Rise as syndromic testing platforms expand in U.S. labs
Medical Devices & Diagnostics

How QIAGEN’s QIAstat-Dx Rise GI panel clearance could reshape multiplex pathogen testing in clinical labs

QIAGEN wins FDA clearance for GI panels on QIAstat-Dx Rise. Discover what this means for syndromic testing platforms and molecular diagnostics adoption.

Read More